Upon matching 79 MYC + with 92 MYC- DLBCL patients for IPI, Ann Arbor stage, and extranodal involvement, MYC status and PET response were still significantly associated (χ2[3, n = 171] = 14.9, p = 0.002). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.